What’s Going On With SoundHound AI Stock?
SoundHound AI shares are down 4.2% Tuesday afternoon. Tuesday’s pullback could be to profit-taking following a remarkable year-to-date rally exceeding 500%. read more
Read More
Arvinas-Pfizer Partner Cancer Drug Trial Shows 63% Clinical Benefit In Breast Cancer Patients
Arvinas and Pfizer share Phase 1b TACTIVE-U trial results showing 62.5% clinical benefit rate and tolerable safety for advanced breast cancer therapy. read more
C3.ai’s Growth Boosted by Microsoft Partnership And AI Expansion Drive, Analysts Up Price Forecast
C3.AI Inc reported Q2 revenue of $93.34M, beating analyst consensus of $91.02M. Analysts raised price targets, with JMP Securities at $55, Needham at Hold, and JP Morgan at $28. C3.ai has had 7 quarters of accelerating revenue growth and a new partnership with Microsoft. Latest Ratings for AI Date Firm Action From To Mar 2022…
Eric Trump Is Confident Bitcoin Is ‘Going To Hit $1 Million’
Eric Trump has lauded Bitcoin (CRYPTO: BTC) as a transformative asset with the potential to disrupt traditional banking systems. read more
What’s Going On With Super Micro Computer Stock?
Shares of Super Micro Computer Inc. (NASDAQ: SMCI) briefly surged Monday morning before pulling back. The stock is continuing to move lower on Tuesday. Here’s what you need to know. read more
Google’s Quantum Willow Chip ‘Lightyears’ From Cracking Bitcoin: Expert
Google’s new quantum computing chip Willow can complete tasks in minutes that would take supercomputers 10 septillion years. It’s not a threat to Bitcoin yet. Quantum computing stocks surge in 2024. read more
GSK’s Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson’s Darzalex
GSK’s Blenrep combo demonstrates significant survival benefits and improved efficacy in relapsed multiple myeloma compared to Darzalex combo. read more